Search
Rani Therapeutics Holdings Inc
RANIAdd to Watchlist
0.774USD
-0.046-5.63%
Close 07-31 16:00（ET）Quotes delayed by 15 min
77.27MMarket Cap
LossP/E TTM
More Details of Rani Therapeutics Holdings Inc Company
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. The Company has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. It has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. It is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).
Rani Therapeutics Holdings Inc Info
Ticker SymbolRANI
Company nameRani Therapeutics Holdings Inc
IPO dateJul 30, 2021
CEOImran (Talat)
Number of employees105
Security typeOrdinary Share
Fiscal year-endJul 30
Address2051 Ringwood Avenue
CitySAN JOSE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code95131
Phone14084573700
Websitehttps://www.ranitherapeutics.com/
Ticker SymbolRANI
IPO dateJul 30, 2021
CEOImran (Talat)
Company Executives of Rani Therapeutics Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Talat Imran
Mr. Talat Imran
Chief Executive Officer, Director
Chief Executive Officer, Director
377.03K
+9.28%
Mr. Svai S. Sanford
Mr. Svai S. Sanford
Chief Financial Officer
Chief Financial Officer
202.86K
+7.65%
Mr. Jean-Luc Butel
Mr. Jean-Luc Butel
Independent Director
Independent Director
50.50K
--
Dr. Mir Hashim
Dr. Mir Hashim
Chief Scientific Officer
Chief Scientific Officer
28.90K
-587.04%
Dr. Dennis A. Ausiello, M.D.
Dr. Dennis A. Ausiello, M.D.
Independent Director
Independent Director
--
--
Mr. Mir Imran
Mr. Mir Imran
Chairman of the Board
Chairman of the Board
--
--
Mr. Eric Groen
Mr. Eric Groen
General Counsel
General Counsel
--
--
Ms. Lisa Rometty
Ms. Lisa Rometty
Independent Director
Independent Director
--
--
Ms. Kate Mckinley
Ms. Kate Mckinley
Chief Business Officer
Chief Business Officer
--
--
Mr. Abraham (Abe) Bassan
Mr. Abraham (Abe) Bassan
Director
Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Talat Imran
Mr. Talat Imran
Chief Executive Officer, Director
Chief Executive Officer, Director
377.03K
+9.28%
Mr. Svai S. Sanford
Mr. Svai S. Sanford
Chief Financial Officer
Chief Financial Officer
202.86K
+7.65%
Mr. Jean-Luc Butel
Mr. Jean-Luc Butel
Independent Director
Independent Director
50.50K
--
Dr. Mir Hashim
Dr. Mir Hashim
Chief Scientific Officer
Chief Scientific Officer
28.90K
-587.04%
Dr. Dennis A. Ausiello, M.D.
Dr. Dennis A. Ausiello, M.D.
Independent Director
Independent Director
--
--
Mr. Mir Imran
Mr. Mir Imran
Chairman of the Board
Chairman of the Board
--
--
FAQs
Who are the top five shareholders of Rani Therapeutics Holdings Inc?
The top five shareholders of Rani Therapeutics Holdings Inc are: Mr. Talat Imran
How many institutions hold shares of Rani Therapeutics Holdings Inc (RANI)?
As of 2026Q1, 118 institutions hold shares of Rani Therapeutics Holdings Inc, with a combined market value of approximately 52.09M, accounting for 52.19% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 19014050.00.